Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Carotegrast Methyl: First Approval
Sohita Dhillon
Drugs (2022) Vol. 82, Iss. 9, pp. 1011-1016
Open Access | Times Cited: 20

Showing 20 citing articles:

Phenotypic characterization of single CD4+ T cells harboring genetically intact and inducible HIV genomes
Caroline Dufour, Corentin Richard, Marion Pardons, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 34
Synthetic Approaches to the New Drugs Approved During 2022
Scott P. France, Erick A. Lindsey, Emma L. McInturff, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 6, pp. 4376-4418
Closed Access | Times Cited: 9
Anoikis in cell fate, physiopathology, and therapeutic interventions
Jie Mei, Xue‐Yao Jiang, Huixiang Tian, et al.
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 8
Emerging Therapies for Ulcerative Colitis: Updates from Recent Clinical Trials
Turki AlAmeel, Abdulelah Almutairdi, Badr Al‐Bawardy
Clinical and Experimental Gastroenterology (2023) Vol. Volume 16, pp. 147-167
Open Access | Times Cited: 13
Scaffold‐Oriented Asymmetric Catalysis: Conformational Modulation of Transition State Multivalency during a Catalyst‐Controlled Assembly of a Pharmaceutically Relevant Atropisomer
Nicolò Tampellini, Brandon Q. Mercado, Scott J. Miller
Chemistry - A European Journal (2024) Vol. 30, Iss. 30
Closed Access | Times Cited: 5
The Role and Research Progress of Integrins, Adhesion Molecules, Partial Chemokines and Other Molecules in Inflammatory Bowel Disease
晓娟 王
Advances in Clinical Medicine (2025) Vol. 15, Iss. 02, pp. 2144-2149
Closed Access
VCAM-1 as a common biomarker in inflammatory bowel disease and colorectal cancer: unveiling the dual anti-inflammatory and anti-cancer capacities of anti-VCAM-1 therapies
Jessica R. Pickett, Yuao Wu, Hang T. Ta
Cancer and Metastasis Reviews (2025) Vol. 44, Iss. 2
Open Access
Roles of anoikis in hepatocellular carcinoma therapy and the assessment of anoikis-regulatory molecules as therapeutic targets
Hongyu Wang, Ya‐Wen Yang, Gan Zhang, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Research advancements and perspectives of inflammatory bowel disease: A comprehensive review
JingShan Bai, Ying Wang, Fuhao Li, et al.
Science Progress (2024) Vol. 107, Iss. 2
Open Access | Times Cited: 3
Synthesis of 3-(Pyridin-2-yl)quinazolin-2,4(1H,3H)-diones via Annulation of Anthranilic Esters with N-pyridyl Ureas
Svetlana O. Baykova, Kirill K. Geyl, Sergey V. Baykov, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7633-7633
Open Access | Times Cited: 8
Novel targets for mucosal healing in inflammatory bowel disease therapy
Pardis Mansouri, Pegah Mansouri, Esmaeil Behmard, et al.
International Immunopharmacology (2024) Vol. 144, pp. 113544-113544
Closed Access | Times Cited: 2
FORWARD: A Learning Framework for Logical Network Perturbations to Prioritize Targets for Drug Development
Saptarshi Sinha, Ella McLaren, Madhubanti Mullick, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Effects of rifampicin on the pharmacokinetics and safety of carotegrast methyl in healthy subjects: A randomized 2 × 2 crossover study
Hiromitsu Imai, Ichiro Oikawa, Tetsuya Koyama, et al.
British Journal of Clinical Pharmacology (2024) Vol. 90, Iss. 6, pp. 1395-1407
Open Access
Research Progress of Therapeutic Drugs for Ulcerative Colitis
肖颖 曹
Pharmacy Information (2024) Vol. 13, Iss. 05, pp. 429-437
Closed Access
Evaluation of the potential drug–drug interactions of carotegrast methyl with midazolam, prednisolone or atorvastatin in healthy adults
Shunji Matsuki, Ichiro Oikawa, Tetsuya Koyama, et al.
British Journal of Clinical Pharmacology (2023) Vol. 90, Iss. 3, pp. 871-881
Open Access | Times Cited: 1
Scaffold-Oriented Asymmetric Catalysis: Conformational Modulation of Transition State Multivalency during a Catalyst-Controlled Assembly of a Pharmaceutically Relevant Atropisomer
Nicolò Tampellini, Brandon Q. Mercado, Scott J. Miller
(2023)
Open Access | Times Cited: 1
Phenotypic characterization of single CD4+ T cells harboring genetically intact and inducible HIV genomes
Caroline Dufour, Corentin Richard, Marion Pardons, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1
Effects of Rifampicin on the Pharmacokinetics and Safety of Carotegrast Methyl in Healthy Subjects: A Randomized 2 x 2 Crossover Study
Hiromitsu Imai, Ichiro Oikawa, Tetsuya Koyama, et al.
Authorea (Authorea) (2023)
Open Access
Evaluation of the potential drug-drug interactions of carotegrast methyl with midazolam, prednisolone, or atorvastatin in healthy adults
Shunji Matsuki, Ichiro Oikawa, Tetsuya Koyama, et al.
Authorea (Authorea) (2023)
Open Access
Future treatment options for inflammatory bowel disease
Franziska Bertram, Jan Kempski, Samuel Huber
Deleted Journal (2023) Vol. 18, Iss. 6, pp. 432-439
Closed Access
Page 1

Scroll to top